Loading…

Glutathione level and glutathione reductase activity in serum of coronary heart disease patients

Introduction: Oxidative stress induced by the generation of excess reactive oxygen species is one of the cause of atherosclerosis finally leading to coronary heart disease (CHD). Glutathione reductase (GR), a flavoprotein antioxidant enzyme, regenerates glutathione (GSH) from its oxidized form, whic...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pre-clinical and clinical research 2017-12, Vol.11 (2), p.103-105
Main Authors: Zuzak, Ewa, Horecka, Anna, Kiełczykowska, Małgorzata, Dudek, Aneta, Musik, Irena, Kurzepa, Joanna, Kurzepa, Jacek
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Oxidative stress induced by the generation of excess reactive oxygen species is one of the cause of atherosclerosis finally leading to coronary heart disease (CHD). Glutathione reductase (GR), a flavoprotein antioxidant enzyme, regenerates glutathione (GSH) from its oxidized form, which is essential for scavenging of hydrogen peroxide by glutathione peroxidase. The aim of this study was to analyze the activity of GR and GSH level in serum of patients with various stages of CHD. Material and methods: Sixty consecutive patients with diagnosis of stable angina (SA, n=20), unstable angina (UA, n=20) and non-fatal myocardial infarction (MI, n=20) together with 20 healthy control subjects were enrolled. Venous blood samples were collected just before the coro-nary catheterization procedure (in study patients). GR activities and GSH concentration was deter-mined using commercially available colorimetric kits. Results: The highest GR activity and GSH serum level was noticed in UA patients. However, sta-tistical evaluation showed that only glutathione reductase activity was significantly higher in serum obtained from myocardial infarction patients, compared to stable angina pectoris patients (19.52 ± 13.88 vs 11.63 ± 5.45 nmol/min/ml for MI and SA, respectively; p
ISSN:1898-2395
1898-7516
DOI:10.26444/jpccr/81277